These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25633200)

  • 1. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
    Hu L; Huang HZ; Li X; Lin XX; Li W
    Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
    Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
    Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].
    Ye XX; Jin YB; Lin XX; Ma G; Chen XD; Qiu YJ; Chen H; Hu XJ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):161-4. PubMed ID: 22870699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
    Danarti R; Ariwibowo L; Radiono S; Budiyanto A
    Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.
    Painter SL; Hildebrand GD
    J AAPOS; 2016 Apr; 20(2):172-174.e1. PubMed ID: 27079600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
    Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of topical beta blockers as treatment for infantile hemangiomas.
    Painter SL; Hildebrand GD
    Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
    Marey HM; Elmazar HF; Mandour SS; Khairy HA
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
    Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical timolol for infantile hemangioma of the eyelid.
    Calvo M; Garcia-Millán C; Villegas C; Fueyo-Casado A; Burón I
    Int J Dermatol; 2013 May; 52(5):603-4. PubMed ID: 22417222
    [No Abstract]   [Full Text] [Related]  

  • 14. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
    Chan H; McKay C; Adams S; Wargon O
    Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
    Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops.
    Xue K; Hildebrand GD
    JAMA Ophthalmol; 2013 Sep; 131(9):1246-8. PubMed ID: 23846584
    [No Abstract]   [Full Text] [Related]  

  • 18. Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
    Rizvi SA; Yusuf F; Sharma R; Rizvi SW
    Semin Ophthalmol; 2015 Jan; 30(1):62-4. PubMed ID: 24074395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid complete regression of an early infantile hemangioma with topical timolol gel.
    Semkova K; Kazandjieva J
    Int J Dermatol; 2014 Feb; 53(2):241-2. PubMed ID: 24261914
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
    Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
    Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.